Company profile: Travanti Pharma
1.1 - Company Overview
Company description
- Provider of innovative drug delivery platforms that improve the safety, compliance, effectiveness, and ease of administration of medications delivered into the body; designs, develops, and markets these platforms to enhance medication delivery.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Travanti Pharma
MannKind
HQ: United States
Website
- Description: Provider of inhaled and wearable therapeutic products and platforms for diabetes and pulmonary diseases, including Afrezza (inhaled insulin), Tyvaso DPI (treprostinil for PAH and PH-ILD), Clofazimine Inhalation Suspension (for NTM lung disease), Nintedanib DPI (for pulmonary fibrotic diseases), V-Go (wearable insulin delivery), and Technosphere Technology for dry powder inhalation formulations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MannKind company profile →
Credence MedSystems
HQ: United States
Website
- Description: Provider of drug delivery and specialty pharmaceutical solutions focused on safe medication administration, offering syringe systems including the Companion Safety Syringe with end-of-dose cues, passive needlestick safety, reuse prevention and pre-attached needle; Dual Chamber Reconstitution Syringe; Credence Connect for real-time injection monitoring; Micro-Dose Syringe for ocular use; and Multi-Site Syringe.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Credence MedSystems company profile →
Sensile Medical
HQ: Switzerland
Website
- Description: Provider of liquid drug delivery devices and platforms developed in Switzerland, offering safe, cost-efficient, customizable on- and off-body solutions—featuring reusable and disposable concepts—for subcutaneous administration of biologics and small molecules, including Gx SensAir, on-body and belt-worn infusors with adjustable flow and connectivity, an inhalation assessment platform, and the Gx Inbeneo autoinjector.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sensile Medical company profile →
Optinose
HQ: Norway
Website
- Description: Provider of nasal drug delivery technologies and combination drug/device therapies based on Bi-Directional Delivery, including Exhalation Delivery Systems for efficient deep nasal delivery. Offerings include XHANCE nasal spray for nasal polyps, ONZETRA Xsail for migraine treatment, and liquid and powder delivery devices using exhaled breath.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Optinose company profile →
Alexza
HQ: United States
Website
- Description: Provider of inhaled therapeutics for acute and intermittent conditions, featuring commercial ADASUVE (loxapine) for acute agitation in adults with schizophrenia or bipolar disorder, and developing Staccato inhalation candidates: alprazolam for epileptic seizures, apomorphine for OFF episodes in Parkinson’s disease, and granisetron for cyclic vomiting syndrome.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alexza company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Travanti Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Travanti Pharma
2.2 - Growth funds investing in similar companies to Travanti Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Travanti Pharma
4.2 - Public trading comparable groups for Travanti Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →